$IZEA
IZEA Worldwide, Inc.

2013 Q4 Form 10-Q Financial Statement

#000149523113000067 Filed on November 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $1.960M $1.566M $1.059M
YoY Change 86.67% 47.88% 0.59%
Cost Of Revenue $850.0K $499.1K $434.0K
YoY Change 51.79% 15.0% -10.28%
Gross Profit $1.110M $1.067M $624.8K
YoY Change 126.53% 70.73% 9.82%
Gross Profit Margin 56.63% 68.12% 59.01%
Selling, General & Admin $1.970M $1.719M $1.555M
YoY Change 27.92% 10.53% -29.27%
% of Gross Profit 177.48% 161.16% 248.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $60.00K $20.00K $30.00K
YoY Change 100.0% -33.33% 200.0%
% of Gross Profit 5.41% 1.87% 4.8%
Operating Expenses $1.980M $1.719M $1.555M
YoY Change 37.5% 10.53% -29.27%
Operating Profit -$870.0K -$652.4K -$930.6K
YoY Change -8.42% -29.89% -42.91%
Interest Expense $300.0K $14.44K $33.50K
YoY Change -3100.0% -56.89% 578.17%
% of Operating Profit
Other Income/Expense, Net $0.00 -$322.9K -$20.95K
YoY Change 1441.48% -153.89%
Pretax Income -$570.0K -$980.0K -$950.0K
YoY Change -40.63% 3.16% -40.25%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$570.0K -$975.3K -$951.6K
YoY Change -40.63% 2.49% -40.2%
Net Earnings / Revenue -29.08% -62.29% -89.87%
Basic Earnings Per Share -$0.08
Diluted Earnings Per Share -$508.9K -$0.08 -$8.636M
COMMON SHARES
Basic Shares Outstanding 22.39M shares 13.00M shares
Diluted Shares Outstanding 13.00M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $530.0K $1.660M $1.300M
YoY Change -19.7% 27.69% 18.18%
Cash & Equivalents $530.1K $530.1K $1.304M
Short-Term Investments
Other Short-Term Assets $83.49K $23.10K $11.63K
YoY Change 618.04% 98.67% -98.43%
Inventory
Prepaid Expenses $110.0K $127.5K $147.6K
Receivables $1.660M $1.164M $692.7K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.383M $2.991M $2.165M
YoY Change 89.03% 38.15% -20.43%
LONG-TERM ASSETS
Property, Plant & Equipment $156.5K $147.8K $124.1K
YoY Change 37.56% 19.11% -24.66%
Goodwill
YoY Change
Intangibles $0.00 $4.500K $76.71K
YoY Change -100.0% -94.13% 248.95%
Long-Term Investments
YoY Change
Other Assets $50.00K $10.00K $20.00K
YoY Change 400.0% -50.0% 0.0%
Total Long-Term Assets $565.4K $405.1K $218.2K
YoY Change 301.55% 85.67% 5.03%
TOTAL ASSETS
Total Short-Term Assets $2.383M $2.991M $2.165M
Total Long-Term Assets $565.4K $405.1K $218.2K
Total Assets $2.949M $3.396M $2.383M
YoY Change 110.38% 42.5% -18.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $817.1K $741.5K $1.051M
YoY Change -29.76% -29.47% 18.65%
Accrued Expenses $365.5K $472.0K $190.0K
YoY Change 94.53% 148.43% 35.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $40.00K $40.00K $20.00K
YoY Change 100.0% 100.0%
Total Short-Term Liabilities $2.519M $2.515M $3.181M
YoY Change -2.97% -20.95% 21.84%
LONG-TERM LIABILITIES
Long-Term Debt $30.00K $30.00K $10.00K
YoY Change -75.0% 200.0% -66.67%
Other Long-Term Liabilities $1.850M $2.140M $40.00K
YoY Change 5250.0% -96.04%
Total Long-Term Liabilities $1.880M $2.170M $50.00K
YoY Change 1466.67% 4240.0% -95.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.519M $2.515M $3.181M
Total Long-Term Liabilities $1.880M $2.170M $50.00K
Total Liabilities $4.400M $4.685M $3.239M
YoY Change 62.05% 44.63% -11.35%
SHAREHOLDERS EQUITY
Retained Earnings -$26.13M -$25.56M -$21.84M
YoY Change 14.57% 17.02% 28.53%
Common Stock $2.256K $2.234K $412.00
YoY Change 264.46% 442.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.451M -$1.289M -$855.9K
YoY Change
Total Liabilities & Shareholders Equity $2.949M $3.396M $2.383M
YoY Change 110.38% 42.5% -18.62%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$570.0K -$975.3K -$951.6K
YoY Change -40.63% 2.49% -40.2%
Depreciation, Depletion And Amortization $60.00K $20.00K $30.00K
YoY Change 100.0% -33.33% 200.0%
Cash From Operating Activities -$940.0K -$650.0K -$710.0K
YoY Change 44.62% -8.45% -22.83%
INVESTING ACTIVITIES
Capital Expenditures -$120.0K -$150.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$40.00K $0.00 $0.00
YoY Change -500.0% -100.0%
Cash From Investing Activities -$160.0K -$160.0K $0.00
YoY Change -1700.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.00K 2.380M 1.820M
YoY Change 30.77% -4650.0%
NET CHANGE
Cash From Operating Activities -940.0K -650.0K -710.0K
Cash From Investing Activities -160.0K -160.0K 0.000
Cash From Financing Activities -40.00K 2.380M 1.820M
Net Change In Cash -1.140M 1.570M 1.110M
YoY Change 78.13% 41.44% -213.27%
FREE CASH FLOW
Cash From Operating Activities -$940.0K -$650.0K -$710.0K
Capital Expenditures -$120.0K -$150.0K $0.00
Free Cash Flow -$820.0K -$500.0K -$710.0K
YoY Change 26.15% -29.58% -22.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
741517 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1163307 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1163664 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
426818 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
187868 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
472025 USD
CY2013Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
46059 USD
CY2012Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
25923 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24265185 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21489354 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
359251 USD
CY2013Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
706000 USD
us-gaap Advertising Cost Policy Expensed Advertising Cost
AdvertisingCostPolicyExpensedAdvertisingCost
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Advertising Costs</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Advertising costs are charged to expense as they are incurred, including payments to contact creators to promote the Company.&#160;&#160;Advertising expense charged to operations for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;"> were approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$12,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$60,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. Advertising expense charged to operations for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;"> were approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$56,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$359,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. Advertising costs are included in sales and marketing expense in the accompanying consolidated statements of operations.</font></div></div>
CY2013Q3 us-gaap Advertising Expense
AdvertisingExpense
12000 USD
us-gaap Advertising Expense
AdvertisingExpense
359000 USD
CY2012Q3 us-gaap Advertising Expense
AdvertisingExpense
60000 USD
us-gaap Advertising Expense
AdvertisingExpense
56000 USD
CY2012Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7666 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
18700 USD
CY2013Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7826 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
20137 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27350213 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1314858 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27350213 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1314858 shares
CY2013Q3 us-gaap Assets
Assets
3396143 USD
CY2012Q4 us-gaap Assets
Assets
1401638 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1260833 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
2991001 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
55369 USD
CY2013Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
40126 USD
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
17638 USD
CY2013Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
30194 USD
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
10212 USD
CY2013Q3 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
146031 USD
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
244878 USD
CY2012Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0 USD
CY2013Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
244878 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1663688 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
657946 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1304012 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
225277 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1005742 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1078735 USD
CY2013Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
349464 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22335543 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6186997 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6186997 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22335543 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
619 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
2234 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Concentrations of credit risk with respect to accounts receivable are typically limited because a large number of geographically diverse customers make up the Company&#8217;s customer base, thus spreading the trade credit risk. The Company also controls credit risk through credit approvals, credit limits and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> customers accounted for </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">38%</font><font style="font-family:inherit;font-size:10pt;"> of total accounts receivable in the aggregate, each of which accounted for more than 10% of the Company&#8217;s accounts receivable. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> customers which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">46%</font><font style="font-family:inherit;font-size:10pt;"> of total accounts receivable in the aggregate. The Company had </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> customers that accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">33%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">13%</font><font style="font-family:inherit;font-size:10pt;"> of its revenue during the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. The Company had </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> customers that accounted for more than 10% of its revenue during the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2013Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.33
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.13
CY2012Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
75000 USD
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
434019 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1593790 USD
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
499127 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1846130 USD
CY2013Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
6903872 shares
CY2013Q3 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
770975 USD
CY2013Q2 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
755227 USD
CY2013Q3 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
523016 USD
CY2013Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
13042 USD
CY2012Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
1877 USD
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1260919 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
207682 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1140140 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
70013 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
87422 USD
CY2013Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
207462 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
738628 USD
CY2012Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
10903 USD
CY2013Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2139967 USD
CY2012Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2750 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.64
CY2012Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
11817 USD
CY2013Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0 USD
CY2013Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
12461 USD
CY2012Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
56989 USD
CY2013Q3 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-39257 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
644 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-558869 USD
CY2013Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-215092 USD
CY2012Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
50160 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
681639 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
72776 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
59276 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4594888 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1335858 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4807610 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1655727 USD
us-gaap Gross Profit
GrossProfit
2820269 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
1066724 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
624817 USD
us-gaap Gross Profit
GrossProfit
2282718 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-28615 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-421790 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
760864 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2119 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
22149 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
310561 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
120779 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
102607 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-8500 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
231982 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-109998 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
1097 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
3650 USD
CY2013Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
93482 USD
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4500 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
33495 USD
us-gaap Interest Expense
InterestExpense
77762 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
14439 USD
us-gaap Interest Expense
InterestExpense
52435 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
668415 USD
us-gaap Interest Paid
InterestPaid
6222 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1401638 USD
us-gaap Interest Paid
InterestPaid
9902 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
384088 USD
CY2013Q3 us-gaap Liabilities
Liabilities
4684748 USD
CY2012Q4 us-gaap Liabilities
Liabilities
2715087 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3396143 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2514587 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2595770 USD
CY2013Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
106355 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3265154 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3569524 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5359 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13967 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2245445 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2485430 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-975302 USD
us-gaap Net Income Loss
NetIncomeLoss
-3708149 USD
us-gaap Net Income Loss
NetIncomeLoss
-2752602 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-951570 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-4672638 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-705288 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20945 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-322863 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-197791 USD
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
75000 USD
CY2013Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2013Q3 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
1586109 USD
CY2013Q2 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
820202 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
1719163 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
1555442 USD
us-gaap Operating Expenses
OperatingExpenses
5793076 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2047314 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-930625 USD
us-gaap Operating Expenses
OperatingExpenses
4867583 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3510358 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-652439 USD
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
23099 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
11627 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
230 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
455 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
150 USD
CY2013Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1646874 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15064 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9009 USD
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
162565 USD
CY2013Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
127508 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Reclassifications</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain items have been reclassified in the 2012 financial statements to conform to the 2013 presentation.</font></div></div>
CY2013Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2182500 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
543700 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1439798 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1099 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
147813 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
113757 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
24018 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
21174 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
206789 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25556024 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22803422 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1058836 USD
us-gaap Sales Revenue Net
SalesRevenueNet
4666399 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1565851 USD
us-gaap Sales Revenue Net
SalesRevenueNet
3876508 USD
CY2012Q4 us-gaap Security Deposit
SecurityDeposit
9048 USD
CY2013Q3 us-gaap Security Deposit
SecurityDeposit
7951 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
63436 USD
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
219584 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
985466 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
272695 USD
us-gaap Share Based Compensation
ShareBasedCompensation
359251 USD
us-gaap Share Based Compensation
ShareBasedCompensation
150878 USD
us-gaap Stock Issued1
StockIssued1
64619 USD
us-gaap Stock Issued1
StockIssued1
0 USD
CY2013Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
4820 USD
CY2012Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
35000 USD
CY2012Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1200 USD
CY2012Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
69445 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
373399 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-1313449 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-1288605 USD
CY2012Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
40
CY2012Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
All current and historical information contained herein related to the share and per share information for the Company's common stock or stock equivalents issued on or after May 12, 2011 reflects the 1-for-40 reverse stock split of the Company's outstanding shares of common stock that became market effective on August 1, 2012.
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9034361 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12996717 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2265222 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2266524 shares
CY2012Q2 izea Cash Paid For Celebrity Endorsements
CashPaidForCelebrityEndorsements
100000 USD
CY2012Q2 izea Classof Warrantor Right Numberof Warrant Holders
ClassofWarrantorRightNumberofWarrantHolders
19 warrantholder
CY2011Q3 izea Common Shares Linked To Derivative Warrants
CommonSharesLinkedToDerivativeWarrants
250 shares
CY2013Q3 izea Compound Embedded Derivatives Change In Fair Value Of Derivatives
CompoundEmbeddedDerivativesChangeInFairValueOfDerivatives
644 USD
CY2013Q2 izea Compoundembeddedderviativeissuanceofpromissorynote
Compoundembeddedderviativeissuanceofpromissorynote
0 USD
izea Conversion Of Notes To Common Stock
ConversionOfNotesToCommonStock
124611 USD
izea Derivative Gain Loss On Derivative Exchange Net
DerivativeGainLossOnDerivativeExchangeNet
732 USD
CY2013Q3 izea Entity Wide Revenue Number Of Major Customer
EntityWideRevenueNumberOfMajorCustomer
2 customer
izea Entity Wide Revenue Number Of Major Customer
EntityWideRevenueNumberOfMajorCustomer
1 customer
CY2012Q1 izea Entity Wide Revenue Number Of Major Customer
EntityWideRevenueNumberOfMajorCustomer
0 customer
izea Fair Value Of Compound Embedded Derivative In Promissory Notes
FairValueOfCompoundEmbeddedDerivativeInPromissoryNotes
0 USD
izea Fair Value Of Compound Embedded Derivative In Promissory Notes
FairValueOfCompoundEmbeddedDerivativeInPromissoryNotes
27776 USD
izea Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
7209 USD
CY2013Q1 izea Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
7209 USD
CY2013Q2 izea Fair Valueof Convertible Notes Payable With Compondembedded Derivative
FairValueofConvertibleNotesPayableWithCompondembeddedDerivative
820202 USD
CY2013Q3 izea Fairvalueofconvertiblenotes
Fairvalueofconvertiblenotes
1586109 USD
CY2012Q4 izea Fairvalueofconvertiblenotes
Fairvalueofconvertiblenotes
0 USD
CY2013Q3 izea Fairvalueofconvertiblenotes
Fairvalueofconvertiblenotes
0 USD
izea Fairvalueofconvertiblenotespayablechangeinderivativefairvalue
Fairvalueofconvertiblenotespayablechangeinderivativefairvalue
765907 USD
CY2013Q3 izea Fairvalueofconvertiblenotespayablechangeinderivativefairvalue
Fairvalueofconvertiblenotespayablechangeinderivativefairvalue
422554 USD
CY2013Q3 izea Income Lossin Fair Valueof Debtand Exchangeof Convertible Notes
IncomeLossinFairValueofDebtandExchangeofConvertibleNotes
-848380 USD
CY2013Q2 izea Increase Decrease In Number Of Shares Linked To Promissory Notes Embedded Derivatives
IncreaseDecreaseInNumberOfSharesLinkedToPromissoryNotesEmbeddedDerivatives
6042000 shares
CY2013Q3 izea Interest Expense Notes Payable
InterestExpenseNotesPayable
3998 USD
CY2012Q3 izea Interest Expense Notes Payable
InterestExpenseNotesPayable
24138 USD
izea Interest Expense Notes Payable
InterestExpenseNotesPayable
22397 USD
izea Interest Expense Notes Payable
InterestExpenseNotesPayable
52840 USD
CY2013Q3 izea Legal Fees Reduction Settledby Issuanceof Restricted Stock
LegalFeesReductionSettledbyIssuanceofRestrictedStock
288081 USD
CY2013Q3 izea Linked Common Shares To Promissory Notes Change In Fair Value Of Derivatives
LinkedCommonSharesToPromissoryNotesChangeInFairValueOfDerivatives
324726 shares
izea Loss On Exchange Of Warrants
LossOnExchangeOfWarrants
94214 USD
CY2013Q3 izea Loss On Exchange Of Warrants
LossOnExchangeOfWarrants
93482 USD
CY2012Q3 izea Loss On Exchange Of Warrants
LossOnExchangeOfWarrants
37610 USD
izea Loss On Exchange Of Warrants
LossOnExchangeOfWarrants
802123 USD
izea Noncashor Part Noncash Conversionof Notesinto Common Stock
NoncashorPartNoncashConversionofNotesintoCommonStock
0 USD
izea Noncashor Part Noncash Conversionof Notesinto Common Stock
NoncashorPartNoncashConversionofNotesintoCommonStock
1501229 USD
CY2012Q4 izea Number Of Common Shares Linked To Promissory Notes Embedded Derivatives
NumberOfCommonSharesLinkedToPromissoryNotesEmbeddedDerivatives
537146 shares
CY2013Q3 izea Number Of Common Shares Linked To Promissory Notes Embedded Derivatives
NumberOfCommonSharesLinkedToPromissoryNotesEmbeddedDerivatives
0 shares
CY2013Q3 izea Number Of Major Customers Accounting For More Than Ten Percent Of Accounts Receivables
NumberOfMajorCustomersAccountingForMoreThanTenPercentOfAccountsReceivables
2 customer
CY2012Q4 izea Number Of Major Customers Accounting For More Than Ten Percent Of Accounts Receivables
NumberOfMajorCustomersAccountingForMoreThanTenPercentOfAccountsReceivables
2 customer
CY2013Q3 izea Paymentsof Stock Issuance Costs Cash
PaymentsofStockIssuanceCostsCash
150355 USD
CY2013Q3 izea Paymentsof Stock Issuance Costs Warrants
PaymentsofStockIssuanceCostsWarrants
2344899 USD
CY2013Q3 izea Percentage Of Accounts Receivable Accounted For By Major Customer
PercentageOfAccountsReceivableAccountedForByMajorCustomer
0.38
CY2012Q4 izea Percentage Of Accounts Receivable Accounted For By Major Customer
PercentageOfAccountsReceivableAccountedForByMajorCustomer
0.46
CY2013Q3 izea Period After Final Closing Dateof Private Placementthat Registration Statement Must Be Filed
PeriodAfterFinalClosingDateofPrivatePlacementthatRegistrationStatementMustBeFiled
P4M
CY2013Q3 izea Period After Final Closing Dateof Private Placementthat Registration Statement Must Be Made Effective
PeriodAfterFinalClosingDateofPrivatePlacementthatRegistrationStatementMustBeMadeEffective
P6M
izea Period Where There Has Been Volatility In Trading Priceof Stock
PeriodWhereThereHasBeenVolatilityInTradingPriceofStock
P2Y
CY2012Q4 izea Prepaidequityfinancingcost
Prepaidequityfinancingcost
0 USD
CY2013Q3 izea Prepaidequityfinancingcost
Prepaidequityfinancingcost
0 USD
izea Proceedsfromissuanceofcommonstockpreferredstockandwarrants
Proceedsfromissuanceofcommonstockpreferredstockandwarrants
2032145 USD
izea Proceedsfromissuanceofcommonstockpreferredstockandwarrants
Proceedsfromissuanceofcommonstockpreferredstockandwarrants
3045899 USD
CY2012Q2 izea Restricted Shares Issued For Celebrity Endorsements
RestrictedSharesIssuedForCelebrityEndorsements
135521 shares
izea Share Based Compensation Arrangement By Share Based Payment Award Current Average Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardCurrentAverageExpectedForfeitureRate
0.5021
CY2013Q3 izea Share Based Compensation Arrangement By Share Based Payment Award Current Average Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardCurrentAverageExpectedForfeitureRate
0.5021
izea Shares Issued During Period Value New Issuesand Conversionof Notes Payable
SharesIssuedDuringPeriodValueNewIssuesandConversionofNotesPayable
1912244 USD
izea Stock Issued During Period Value Exchange Of Warrants
StockIssuedDuringPeriodValueExchangeOfWarrants
732 USD
izea Stock Issued During Period Value Increaseto Common Stockand Additional Paidin Capital
StockIssuedDuringPeriodValueIncreasetoCommonStockandAdditionalPaidinCapital
1912244 USD
CY2013Q1 izea Warrant Issued In Financing Arrangement Period Of Maturity
WarrantIssuedInFinancingArrangementPeriodOfMaturity
P5Y
CY2013Q1 izea Warrant Issued Not Yet Exercised
WarrantIssuedNotYetExercised
58139 shares
CY2013Q1 izea Warrant Issued Not Yet Exercised Price Per Share
WarrantIssuedNotYetExercisedPricePerShare
0.258
CY2013Q1 izea Warrant Issued Not Yet Exercised Value
WarrantIssuedNotYetExercisedValue
15000 USD
CY2013Q3 izea Warrants Fair Valueat Issuance
WarrantsFairValueatIssuance
2344899 USD
izea Warrants Issued In Financing Arrangement
WarrantsIssuedInFinancingArrangement
49170 USD
izea Warrants Issued In Financing Arrangement
WarrantsIssuedInFinancingArrangement
2352108 USD
CY2013Q3 izea Warrantsandrestrictedstockreservedforfurtureissuancevalue
Warrantsandrestrictedstockreservedforfurtureissuancevalue
1082642 USD
CY2013Q2 izea Warrantsandrestrictedstockreservedforfurtureissuancevalue
Warrantsandrestrictedstockreservedforfurtureissuancevalue
1526202 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001495231
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22389331 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 dei Entity Public Float
EntityPublicFloat
1506252 USD
dei Entity Registrant Name
EntityRegistrantName
IZEA, INC.
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0001495231-13-000067-index-headers.html Edgar Link pending
0001495231-13-000067-index.html Edgar Link pending
0001495231-13-000067.txt Edgar Link pending
0001495231-13-000067-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
izea-20130930.xml Edgar Link completed
izea-20130930.xsd Edgar Link pending
izea-20130930_cal.xml Edgar Link unprocessable
izea-20130930_def.xml Edgar Link unprocessable
izea-20130930_lab.xml Edgar Link unprocessable
izea-20130930_pre.xml Edgar Link unprocessable
izea13093010q.htm Edgar Link pending
izea130930ex311.htm Edgar Link pending
izea130930ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending